Category: Getinge ABSyndicate content

Biomet puts itself back on public market | Medtech Wall Street news for the week of Mar. 10, 2014

March 13, 2014 by MassDevice staff

Here's a look at some of the top Wall Street stories for medical device companies this week.

Biomet announces IPO plans

March 7, 2014 by Brad Perriello

Biomet announces IPO plans

Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.

Siemens, GE named among worst-performing device makers of the year | MassDevice.com On Call

March 12, 2014 by Arezu Sarvestani

QMed releases a list of the 5 worst-performing medical device companies of early 2014, including Siemens, GE and Fresenius, among others.

MassDevice.com On Call

MASSDEVICE ON CALL — Medtech giants have seen Wall Street bumps so far this year, but several of the company's in the industry's top 40 haven't been so fortunate.

M&A: KCI sells Therapeutic Support Systems business to Getinge for $275 million

August 15, 2012 by MassDevice staff

Medical Device company Kinetic Concepts divests unit which makes therapeutic beds, mattress replacement systems and other support surfaces to Getinge for $275 million.

Kinetic Concepts Inc. logo

Kinetic Concepts is selling its Therapeutic Support Systems business to Getinge AB for $275 million, as the company looks to focus on its core wound care business.

3M touts record sales and earnings per share for 2011 | Earnings Roundup

January 27, 2012 by MassDevice staff

3M's 4th-quarter profits beat The Street as it affirms its 2012 guidance, but shares stay flat; also, Hill-Rom's Q1 earnings slide 7%; Getinge sees 2011 profits rise 11% despite sales slide; ResMed's Q2 sales, earnings rise; Uroplasty pares Q3 losses on doubled sales; Encision swings to Q3 losses; and EnteroMedics' Q4, 2011 losses rise.

3M Co.

3M Co. (NYSE:MMM) beat expectations for its 4th-quarter profits and affirmed its guidance for 2012, but Wall Street remained unmoved, with shares staying flat in this morning's trading.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Maquet restructures to meet shifting OR needs

December 8, 2011 by MassDevice staff

Getinge Group subsidiary Maquet restructures its U.S. sales and services organization to meet the growing hybrid operating room market.

maquet

Getinge Group subsidiary Maquet restructured the organization of its U.S. sales and services to meet the growing hybrid operating room market.

Hybrid OR's contain both a traditional operating room and a cardiac catheterization lab, minimizing the need to move a sick patient from room to room for complex procedures.

The suites are designed to foster collaboration between cardiologists, cardiac surgeons, interventional radiologists and vascular surgeons and build a more efficient workflow.

J&J unit completes SterilMed acquisition | Acquisitions Roundup

November 7, 2011 by MassDevice

Johnson & Johnson's Ethicon Endo-Surgery completes its acquisition of medical device reprocessor SterilMed.



Johnson & Johnson's (NYSE:JNJ) Ethicon Endo-Surgery division finished its acquisition of Minnesota-based medical device reprocessor SterilMed Inc for an undisclosed amount.

SterilMed reprocesses medical devices and provides equipment repair and pre-owned equipment sales services. Johnson & Johnson said it plans to keep the SterilMed brand running as it integrates the business into the EES segment.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxter boosts forecast after strong Q3 | Earnings Roundup

October 21, 2011 by MassDevice staff

Baxter International raised the lower end of its full-year earnings forecast after posting strong third-quarter results; also, Danaher's profits slide despite strong sales; ICU Medical's Q3 sales stay flat, profits tick up; Getinge posts a profit but top line declines; Kensey Nash's Q1 2012 profits plunge; and Utah Medical's Q3 sales, earnings soar.

Baxter International

Baxter International Inc. (NYSE:BAX) said it now expects to post earnings of at least $4.29 per share this year, after logging strong third-quarter results.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp